ATE246515T1 - Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac - Google Patents
Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenacInfo
- Publication number
- ATE246515T1 ATE246515T1 AT94918361T AT94918361T ATE246515T1 AT E246515 T1 ATE246515 T1 AT E246515T1 AT 94918361 T AT94918361 T AT 94918361T AT 94918361 T AT94918361 T AT 94918361T AT E246515 T1 ATE246515 T1 AT E246515T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- oral dosage
- formulations containing
- dosage formulations
- containing diclofenac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH171193 | 1993-06-08 | ||
| PCT/EP1994/001662 WO1994028936A1 (en) | 1993-06-08 | 1994-05-24 | Process for the preparation of an oral solid dosage form containing diclofenac |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246515T1 true ATE246515T1 (de) | 2003-08-15 |
Family
ID=4216820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94918361T ATE246515T1 (de) | 1993-06-08 | 1994-05-24 | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5702724A (de) |
| EP (1) | EP0701449B1 (de) |
| JP (2) | JPH08511009A (de) |
| AT (1) | ATE246515T1 (de) |
| AU (1) | AU6971294A (de) |
| CA (1) | CA2163111C (de) |
| DE (1) | DE69433012T2 (de) |
| DK (1) | DK0701449T3 (de) |
| ES (1) | ES2204918T3 (de) |
| FI (1) | FI116039B (de) |
| NO (1) | NO315844B1 (de) |
| NZ (1) | NZ267417A (de) |
| PT (1) | PT701449E (de) |
| WO (1) | WO1994028936A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0800384T3 (da) * | 1994-12-14 | 2001-04-17 | Enbalt Trading Ltd | Pharmaceutiske tabletformuleringer til direkte kompression |
| HUP9600758A2 (en) * | 1996-03-27 | 1998-03-02 | Cyclolab Ciklodextrin Kutato F | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption |
| US6720005B1 (en) * | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
| PE20020351A1 (es) * | 2000-09-11 | 2002-06-14 | Novartis Ag | Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2 |
| PE20030323A1 (es) * | 2001-08-31 | 2003-05-12 | Novartis Ag | Composicion farmaceutica |
| JP2005298338A (ja) * | 2002-02-27 | 2005-10-27 | Eisai Co Ltd | 速崩壊性圧縮成形製剤 |
| AU2003227039B2 (en) * | 2002-03-07 | 2007-04-19 | Novartis Ag | Pharmaceutical compositions |
| US20040241234A1 (en) * | 2003-06-02 | 2004-12-02 | Alpharma, Inc. | Controlled release press-coated formulations of water-soluble active agents |
| DE102004060914A1 (de) * | 2004-12-17 | 2006-07-06 | Bioghurt Biogarde Gmbh & Co. Kg | Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen |
| EP1707217A1 (de) * | 2004-12-17 | 2006-10-04 | Wacker Chemie AG | Methode zur Herstellung eines Alpha-Liponsaure/cyclodextrin Komplexes sowie das hersgestellte Produkt |
| WO2007112272A2 (en) * | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
| CN101410012A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的非甾体抗炎药和β-环糊精的制剂 |
| EP2323976A4 (de) * | 2008-08-14 | 2014-07-02 | Shasun Chemicals And Drugs Ltd | Arylalkylcarboxylsäuresalze, verfahren zu ihrer herstellung und dosierungsformen davon |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5959632A (ja) * | 1982-09-28 | 1984-04-05 | Teikoku Chem Ind Corp Ltd | 徐放性組成物 |
| JPS5984821A (ja) * | 1982-11-04 | 1984-05-16 | Teikoku Chem Ind Corp Ltd | 徐溶化組成物 |
| FR2660195B1 (fr) * | 1990-03-28 | 1994-10-07 | Crinex Sa Laboratoires | Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique. |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| ATE113202T1 (de) * | 1990-11-29 | 1994-11-15 | Wei Ming Pharmaceutical Mfg Co | Hilfsträger für direkte verpressung. |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
-
1994
- 1994-05-24 NZ NZ267417A patent/NZ267417A/en not_active IP Right Cessation
- 1994-05-24 CA CA2163111A patent/CA2163111C/en not_active Expired - Lifetime
- 1994-05-24 JP JP7501246A patent/JPH08511009A/ja active Pending
- 1994-05-24 PT PT94918361T patent/PT701449E/pt unknown
- 1994-05-24 WO PCT/EP1994/001662 patent/WO1994028936A1/en active IP Right Grant
- 1994-05-24 US US08/556,979 patent/US5702724A/en not_active Expired - Lifetime
- 1994-05-24 DK DK94918361T patent/DK0701449T3/da active
- 1994-05-24 DE DE69433012T patent/DE69433012T2/de not_active Expired - Lifetime
- 1994-05-24 ES ES94918361T patent/ES2204918T3/es not_active Expired - Lifetime
- 1994-05-24 AT AT94918361T patent/ATE246515T1/de active
- 1994-05-24 EP EP94918361A patent/EP0701449B1/de not_active Expired - Lifetime
- 1994-05-24 AU AU69712/94A patent/AU6971294A/en not_active Abandoned
-
1995
- 1995-12-04 FI FI955837A patent/FI116039B/fi not_active IP Right Cessation
- 1995-12-06 NO NO19954952A patent/NO315844B1/no not_active IP Right Cessation
-
2005
- 2005-05-31 JP JP2005160207A patent/JP2005247874A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2204918T3 (es) | 2004-05-01 |
| DK0701449T3 (da) | 2003-11-10 |
| NO954952D0 (no) | 1995-12-06 |
| DE69433012T2 (de) | 2004-06-09 |
| PT701449E (pt) | 2003-12-31 |
| US5702724A (en) | 1997-12-30 |
| CA2163111C (en) | 2010-10-26 |
| FI955837A0 (fi) | 1995-12-04 |
| FI116039B (fi) | 2005-09-15 |
| AU6971294A (en) | 1995-01-03 |
| EP0701449A1 (de) | 1996-03-20 |
| NZ267417A (en) | 1997-02-24 |
| CA2163111A1 (en) | 1994-12-22 |
| NO315844B1 (no) | 2003-11-03 |
| DE69433012D1 (de) | 2003-09-11 |
| WO1994028936A1 (en) | 1994-12-22 |
| NO954952L (no) | 1995-12-06 |
| JP2005247874A (ja) | 2005-09-15 |
| FI955837A (fi) | 1995-12-04 |
| EP0701449B1 (de) | 2003-08-06 |
| JPH08511009A (ja) | 1996-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR27835A (tr) | Sübstitüe edilmis azadiokzasikloalkenler. | |
| PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
| ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| ATE246515T1 (de) | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac | |
| EP1026157A3 (de) | Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu | |
| ATE112239T1 (de) | Vaterit und verfahren zu dessen herstellung. | |
| FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
| DE69314779T2 (de) | Prozess zur herstellung von beta-phenylisoserin und analogen verbindungen | |
| ATE110723T1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
| ATE216237T1 (de) | Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade | |
| ATE173922T1 (de) | 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| ATE160938T1 (de) | Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung | |
| DE59409413D1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| AU4304596A (en) | A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same | |
| TW261605B (de) | ||
| ATE121626T1 (de) | Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut. | |
| DE69514512T2 (de) | Verfahren zur herstellung von benzopyranderivaten | |
| DE59504643D1 (de) | Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
| ATE32514T1 (de) | 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0701449 Country of ref document: EP |